Anabolic-androgenic steroids abuse
Research data indicates that steroids affect the serotonin and dopamine neurotransmitter systems of the brain.[1] In an animal study, male rats developed a conditioned place preference to testosterone injections into the nucleus accumbens, an effect blocked by dopamine antagonists, which suggests that androgen reinforcement is mediated by the brain. Moreover, testosterone appears to act through the mesolimbic dopamine system, a common substrate for drugs of abuse. Nonetheless, androgen reinforcement is not comparable to that of cocaine, nicotine, or heroin. Instead, testosterone resembles other mild reinforcers, such as caffeine, or benzodiazepines. The potential for androgen addiction remains to be determined.[2]
Anabolic steroids are not psychoactive and cannot be detected by stimuli devices like a pupilometer which makes them hard to spot as a source of neuropsychological imbalaces in some AAS users.
Abuse potential
The Diagnostic Statistical Manual IV (DSM IV) and the International Classification of Diseases, Volume 10 (ICD 10) differ in the way they regard Anabolic-Androgenic Steroids' (AAS) potential for producing dependence.
DSM IV regards AAS as potentially dependence producing. ICD 10 however regards them as non-dependence producing.[3] Anabolic steroids are not physically addictive but users can develop a psychological dependence on the physical result.[4]
Diagnostic Statistical Manual
For DSM-IV, anabolic-androgenic steroid dependency is found in the “other substance-related disorder” (include inhalants, anabolic steroids, medications) section and can be coded, depending on which diagnostic criteria are met.[5]
International Classification of Diseases
ICD–10 criteria for dependence include experience of at least three of the following during the past year:[6]
- a strong desire to take steroids
- difficulty in controlling use
- withdrawal syndrome when use is reduced
- evidence of tolerance
- neglect of other interests and persistent use despite harmful consequences
However, the following ICD-10-CM Index entries contain back-references to ICD-10-CM F55.3:[7]
- Abuse
- hormones F55.5
- steroids F55.5
- drug NEC (non-dependent) F19.10
- hormones F55.5
- steroids F55.5
- non-psychoactive substance NEC F55.8
- hormones F55.5
- steroids F55.5
ICD-10 goes on to state that “although it is usually clear that the patient has a strong motivation to take the substance, there is no development of dependence or withdrawal symptoms as in the case of the psychoactive substances.”[5]
ICD-9-CM will be replaced by ICD-10-CM beginning October 1, 2014, therefore, F55.3 and all other ICD-10-CM diagnosis codes should only be used for training or planning purposes until then.
National Institute on Drug Abuse
The National Institute on Drug Abuse (NIDA) says that "even though anabolic steroids do not cause the same high as other drugs, steroids are reinforcing and can lead to addiction. Studies have shown that animals will self-administer steroids when given the opportunity, just as they do with other addictive drugs. People may persist in abusing steroids despite physical problems and negative effects on social relationships, reflecting these drugs’ addictive potential. Also, steroid abusers typically spend large amounts of time and money obtaining the drug; another indication of addiction. Individuals who abuse steroids can experience withdrawal symptoms when they stop taking them, including mood swings, fatigue, restlessness, loss of appetite, insomnia, reduced sex drive, and steroid cravings, all of which may contribute to continued abuse. One of the most dangerous withdrawal symptoms is depression. When depression is persistent, it can sometimes lead to suicidal thoughts. Research has found that some steroid abusers turn to other drugs such as opioid to counteract the negative effects of steroids."[8]
Causes and treatment
Male anabolic-androgenic steroid abusers often have a troubled social background.[9]
Childhood trauma
25% of male weightlifters reported memories of childhood physical or sexual abuse in an interview. Anabolic steroids are sometimes used by people with muscle dysmorphia (a very specific type of body dysmorphic disorder (BDD)) as a defense mechanism.[10] Interestingly, yohimbine, while it was originally considered a flop of a supplement, because it did not increase testosterone levels as first suspected, have at higher doses been discovered to be useful to facilitate recall of traumatic memories in the treatment of post traumatic stress disorder (PTSD).[11]
References
- ↑ Dopinglinkki > Anabolic steroids induce long-term changes in the brain
- ↑ Wood RI (November 2004). "Reinforcing aspects of androgens". Physiol. Behav. 83 (2): 279–89. doi:10.1016/j.physbeh.2004.08.012. PMID 15488545.
- ↑ Midgley SJ, Heather N, Davies JB (1999). "Dependence-Producing Potential of Anabolic-Androgenic Steroids". Addiction Research & Theory 7 (6): 539–550. doi:10.3109/16066359909004404.
- ↑ "The price of steroids | Men's Fitness UK". Mensfitness.co.uk. 2008-09-03. Retrieved 2013-12-01.
- 1 2 Scally MC, Tan RS (October 2009). "Complexities in clarifying the diagnostic criteria for anabolic-androgenic steroid dependence". Am J Psychiatry 166 (10): 1187; author reply 1188. doi:10.1176/appi.ajp.2009.09060846. PMID 19797448.
- ↑ Rashid H, Ormerod S, Day E (2007). "Anabolic androgenic steroids: What the psychiatrist needs to know". Advances in Psychiatric Treatment 13 (3): 203–211. doi:10.1192/apt.bp.105.000935.
- ↑ "2014 ICD-10-CM Diagnosis Code F55.3 : Abuse of steroids or hormones". Icd10data.com. Retrieved 2013-12-01.
- ↑ "DrugFacts: Anabolic Steroids | National Institute on Drug Abuse". Drugabuse.gov. Retrieved 2013-12-01.
- ↑ Skarberg K, Engstrom I (2007). "Troubled social background of male anabolic-androgenic steroid abusers in treatment". Subst Abuse Treat Prev Policy 2: 20. doi:10.1186/1747-597X-2-20. PMC 1995193. PMID 17615062.
- ↑ "Why do people abuse anabolic steroids? | National Institute on Drug Abuse". Drugabuse.gov. Retrieved 2013-12-01.
- ↑ van der Kolk, Bessel A. (1995). "The Treatment of Post Traumatic Stress Disorder". In Hobfoll, Stevan E.; De Vries, Marten W. Extreme stress and communities: impact and intervention. Boston: Kluwer Academic Publishers. pp. 421–44. ISBN 978-0-7923-3468-2.